Translator Disclaimer
6 August 2014 Use of the CRISPR/Cas9 System to Produce Genetically Engineered Pigs from In Vitro-Derived Oocytes and Embryos
Kristin M. Whitworth, Kiho Lee, Joshua A. Benne, Benjamin P. Beaton, Lee D. Spate, Stephanie L. Murphy, Melissa S. Samuel, Jiude Mao, Chad O'Gorman, Eric M. Walters, Clifton N. Murphy, John Driver, Alan Mileham, David McLaren, Kevin D. Wells, Randall S. Prather
Author Affiliations +
Abstract

Targeted modification of the pig genome can be challenging. Recent applications of the CRISPR/Cas9 system hold promise for improving the efficacy of genome editing. When a designed CRISPR/Cas9 system targeting CD163 or CD1D was introduced into somatic cells, it was highly efficient in inducing mutations. When these mutated cells were used with somatic cell nuclear transfer, offspring with these modifications were created. When the CRISPR/Cas9 system was delivered into in vitro produced presumptive porcine zygotes, the system was effective in creating mutations in eGFP, CD163, and CD1D (100% targeting efficiency in blastocyst stage embryos); however, it also presented some embryo toxicity. We could also induce deletions in CD163 or CD1D by introducing two types of CRISPRs with Cas9. The system could also disrupt two genes, CD163 and eGFP, simultaneously when two CRISPRs targeting two genes with Cas9 were delivered into zygotes. Direct injection of CRISPR/Cas9 targeting CD163 or CD1D into zygotes resulted in piglets that have mutations on both alleles with only one CD1D pig having a mosaic genotype. We show here that the CRISPR/Cas9 system can be used by two methods. The system can be used to modify somatic cells followed by somatic cell nuclear transfer. System components can also be used in in vitro produced zygotes to generate pigs with specific genetic modifications.

Kristin M. Whitworth, Kiho Lee, Joshua A. Benne, Benjamin P. Beaton, Lee D. Spate, Stephanie L. Murphy, Melissa S. Samuel, Jiude Mao, Chad O'Gorman, Eric M. Walters, Clifton N. Murphy, John Driver, Alan Mileham, David McLaren, Kevin D. Wells, and Randall S. Prather "Use of the CRISPR/Cas9 System to Produce Genetically Engineered Pigs from In Vitro-Derived Oocytes and Embryos," Biology of Reproduction 91(3), (6 August 2014). https://doi.org/10.1095/biolreprod.114.121723
Received: 21 May 2014; Accepted: 1 July 2014; Published: 6 August 2014
JOURNAL ARTICLE
PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top